Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans

International Journal of Obesity

Volumn 39, Issue 7, 2015, Pages 1151-1160

  Virtue, S ^a   Masoodi, M ^b,c   De Weijer, B A M ^d   Van Eijk, M ^d   Mok, C Y L ^a   Eiden, M ^b,e   Dale, M ^a   Pirraco, A ^a   Serlie, M J ^d   Griffin, J L ^b,f   Vidal Puig, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e Metabolomx   (United States)

^f Department of Biochemistry ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; INSULIN; MESSENGER RNA; PROSTAGLANDIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2;

ANIMAL EXPERIMENT; ARTICLE; BARIATRIC SURGERY; CELL POLARITY; CELL STRESS; CONTROLLED STUDY; DIET INDUCED OBESITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INSULIN SENSITIVITY; LIQUID CHROMATOGRAPHY; MACROPHAGE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; WHITE ADIPOSE TISSUE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DIET; DISEASE MODEL; INFLAMMATION; LIPID METABOLISM; METABOLISM; MOUSE MUTANT; OBESITY;

MUS;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CHROMATOGRAPHY, LIQUID; DIET; DISEASE MODELS, ANIMAL; EICOSANOIDS; HUMANS; INFLAMMATION; LIPID METABOLISM; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PROSTAGLANDIN D2;

EID: 84936846183     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.34     Document Type: Article

References (46)

1. Virtue S, Vidal-Puig A. Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome-an allostatic perspective. Biochim Biophys Acta 2010; 1801: 338-349.
2. Hopkins NK, Gorman RR. Regulation of 3T3-L1 fibroblast differentiation by prostacyclin (prostaglandin I2). Biochim Biophys Acta 1981; 663: 457-466.
3. Catalioto RM, Gaillard D, Maclouf J, Ailhaud G, Negrel R. Autocrine control of adipose cell differentiation by prostacyclin and PGF2 alpha. Biochim Biophys Acta 1991; 1091: 364-369.
4. Strong P, Coleman RA, Humphrey PP. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors. Prostaglandins 1992; 43: 559-566.
5. Vassaux G, Gaillard D, Ailhaud G, Negrel R. Prostacyclin is a specific effector of adipose cell differentiation. Its dual role as a cAMP-and Ca(2+)-elevating agent. J Biol Chem 1992; 267: 11092-11097.
6. Vassaux G, Gaillard D, Darimont C, Ailhaud G, Negrel R. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 1992; 131: 2393-2398.
7. Casimir DA, Miller CW, Ntambi JM. Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells. Differentiation 1996; 60: 203-210.
8. Miller CW, Casimir DA, Ntambi JM. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha. Endocrinology 1996; 137: 5641-5650.
9. Reginato MJ, Krakow SL, Bailey ST, Lazar MA. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J Biol Chem 1998; 273: 1855-1858.
10. Jaworski K, Ahmadian M, Duncan RE, Sarkadi-Nagy E, Varady KA, Hellerstein MK et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med 2009; 15: 159-168.
11. Sanchez-Alavez M, Klein I, Brownell SE, Tabarean IV, Davis CN, Conti B et al. Night eating and obesity in the EP3R-deficient mouse. Proc Natl Acad Sci USA 2007; 104: 3009-3014.
12. Flachs P, Ruhl R, Hensler M, Janovska P, Zouhar P, Kus V et al. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 2011; 54: 2626-2638.
13. Gonzalez-Periz A, Horrillo R, Ferre N, Gronert K, Dong B, Moran-Salvador E et al. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J 2009; 23: 1946-1957.
14. Neuhofer A, Zeyda M, Mascher D, Itariu BK, Murano I, Leitner L et al. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013; 62: 1945-1956.
15. Claria J, Dalli J, Yacoubian S, Gao F, Serhan CN. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. J Immunol 2012; 189: 2597-2605.
16. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
17. Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY et al. Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J Clin Invest 2007; 117: 1658-1669.
18. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V, Mukundan L et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007; 447: 1116-1120.
19. Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 2008; 8: 301-309.
20. Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: connecting inflammation & metabolism. Biochim Biophys Acta 2014; 1851: 503-518.
21. Dobrian AD, Galkina EV, Ma Q, Hatcher M, Aye SM, Butcher MJ et al. STAT4 deficiency reduces obesity-induced insulin resistance and adipose tissue inflammation. Diabetes 2013; 62: 4109-4121.
22. Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013; 17: 411-422.
23. Weng SY, Schuppan D. AMPK regulates macrophage polarization in adipose tissue inflammation and NASH. J Hepatol 2013; 58: 619-621.
24. Eguchi J, Kong X, Tenta M, Wang X, Kang S, Rosen ED. Interferon regulatory factor 4 regulates obesity-induced inflammation through regulation of adipose tissue macrophage polarization. Diabetes 2013; 62: 3394-3403.
25. Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA et al. JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. Science 2013; 339: 218-222.
26. Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest 2011; 121: 2736-2749.
27. Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med 2012; 18: 1279-1285.
28. Chatterjee P, Seal S, Mukherjee S, Kundu R, Ray S, Mukhopadhyay S et al. Adipocyte fetuin-A contributes to macrophage migration into adipose tissue and polarization of macrophages. J Biol Chem 2013; 288: 28324-28330.
29. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulinsensitizing effects. Cell 2010; 142: 687-698.
30. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
31. Oliveira AG, Araujo TG, Carvalho BM, Guadagnini D, Rocha GZ, Bagarolli RA et al. Acute exercise induces a phenotypic switch in adipose tissue macrophage polarization in diet-induced obese rats. Obesity (Silver Spring) 2013; 21: 2545-2556.
32. Masoodi M, Eiden M, Koulman A, Spaner D, Volmer DA. Comprehensive lipidomics analysis of bioactive lipids in complex regulatory networks. Anal Chem 2010; 82: 8176-8185.
33. de Weijer BA, Aarts E, Janssen IM, Berends FJ, van de Laar A, Kaasjager K et al. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery. Obesity (Silver Spring) 2013; 21: 1143-1147.
34. Bresson E, Boucher-Kovalik S, Chapdelaine P, Madore E, Harvey N, Laberge PY et al. The human aldose reductase AKR1B1 qualifies as the primary prostaglandin F synthase in the endometrium. J Clin Endocrinol Metab 2011; 96: 210-219.
35. Kabututu Z, Manin M, Pointud JC, Maruyama T, Nagata N, Lambert S et al. Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J Biochem 2009; 145: 161-168.
36. Lambert-Langlais S, Pointud JC, Lefrancois-Martinez AM, Volat F, Manin M, Coudore F et al. Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions. PLoS One 2009; 4: e7309.
37. Volat FE, Pointud JC, Pastel E, Morio B, Sion B, Hamard G et al. Depressed levels of prostaglandin F2alpha in mice lacking Akr1b7 increase basal adiposity and predispose to diet-induced obesity. Diabetes 2012; 61: 2796-2806.
38. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat 2002; 68-69: 375-382.
39. Rajaram S, Oono Y. NeatMap-non-clustering heat map alternatives in R. BMC Bioinformatics 2010; 11: 45.
40. Prieur X, Mok CY, Velagapudi VR, Nunez V, Fuentes L, Montaner D et al. Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice. Diabetes 2011; 60: 797-809.
41. Shepherd PR, Kahn BB. Glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341: 248-257.
42. Hetu PO, Riendeau D. Down-regulation of microsomal prostaglandin E2 synthase-1 in adipose tissue by high-fat feeding. Obesity (Silver Spring) 2007; 15: 60-68.
43. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011; 31: 986-1000.
44. Ruan H, Zarnowski MJ, Cushman SW, Lodish HF. Standard isolation of primary adipose cells from mouse epididymal fat pads induces inflammatory mediators and down-regulates adipocyte genes. J Biol Chem 2003; 278: 47585-47593.
45. Fujitani Y, Aritake K, Kanaoka Y, Goto T, Takahashi N, Fujimori K et al. Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. FEBS J 2010; 277: 1410-1419.
46. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK et al. Proinflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656.